Essenvia, a Los Angeles, CA-based company which specializes in regulatory submission management for the MedTech industry, raised $4M in Pre-Series A funding.
The round was led by Benhamou Global Ventures and Wavemaker360 with participation from existing investors First Rays, Rebright partners, as well as Pasadena Angels. Wavemaker360 partner Kwame Ulmer and BGV Partner Yashwanth Hemaraj joined Essenvia’s board of directors.
The company intends to use the funds to expand operations and its business reach.
Led by CEO Soumya Mahapatra, Essenvia specializes in regulatory submission management for the MedTech industry. Unlike conventional Regulatory Information Management (RIM) tools, documents, or spreadsheets, it has zero technical implementation time and works with a regulatory team’s existing process. The platform empowers teams to natively collaborate on 510(k), MDR and IVDR submissions directly inside of a submission, error check them, dynamically publish and re-publish them, and instantly submit using the latest agency-specific technical requirements.
